BYAH
NASDAQPark Ha Biological Technology Co. Ltd.
Price$1.37-0.25 (-15.43%)
12:00 PM07:45 PM
News · 26 weeks34+500%
2025-12-282026-06-21
Mix2290d
- Other7(32%)
- SEC Filings7(32%)
- Insider6(27%)
- Offering2(9%)
Latest news
25 items- SECSEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- PRPark Ha Biological Technology Co., Ltd. announces strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK) to build an AI-driven ecosystem for the beauty industry.Wuxi, China, June 23, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) ("Park Ha Biological" or the "Company") announced that the Company has established a comprehensive strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK), a company listed on The Stock Exchange of Hong Kong ("Cloud Factory"). The two parties will jointly develop a specialized AI-driven ecosystem tailored for the beauty industry, leveraging cross-domain technological collaboration to transcend traditional growth limitations in the sector and usher in a new era of AI-powered, lean operations. The traditional offline beauty business model has long faced widespread op
- SECSEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- PRPark Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct OfferingWuxi, China, June 15, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ:BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the "Company"), today announced the closing of its previously announced registered direct offering with several investors for the sale and purchase of an aggregate of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.001 each (the "Class A Ordinary Shares"), and pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 200,000 Class A Ordinary Shares, at a combined purchase price of $1.50 per Class A Ordinary Share and Pre-Funded Warrant. The gross proceeds to the Co
- SECSEC Form 424B5 filed by Park Ha Biological Technology Co. Ltd.424B5 - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- SECSEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- PRPark Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct OfferingWuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ:BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the "Company"), today announced that it has entered into a securities purchase agreement with several investors for the sales of the Company's securities in a registered direct offering (the "Offering") consisting of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.001 each (the "Shares"), and pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 200,000 Class A ordinary shares (the "Warrant Shares"), at a combined purchase price of $1.50 per Share and Pre-Funded
- SECSEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- PRPark Ha Biological Technology Co., Ltd. announces strategic partnership with Star Plus Legend Group's wholly-owned subsidiary to build an AI-powered skincare and health ecosystem and expand its healthcare reachWuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) ("Park Ha Biological" or the "Company") announced that the Company has established a comprehensive strategic partnership with Star Plus Action (HK) Limited ("Star Plus Action"), a wholly-owned subsidiary of Star Plus Legend Holdings Limited (6683.HK), a company listed on The Stock Exchange of Hong Kong ("Star Plus Legend"). The two parties will integrate resources in the healthcare industry, skincare product development, celebrity IP management, and artificial intelligence technology to jointly advance the beauty and wellness sector, creating an innovative business model that combines AI t
- SECSEC Form EFFECT filed by Park Ha Biological Technology Co. Ltd.EFFECT - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- SECSEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- SECAmendment: SEC Form F-3/A filed by Park Ha Biological Technology Co. Ltd.F-3/A - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- SECAmendment: SEC Form F-3/A filed by Park Ha Biological Technology Co. Ltd.F-3/A - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- SECAmendment: SEC Form 20-F/A filed by Park Ha Biological Technology Co. Ltd.20-F/A - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- SECAmendment: SEC Form 20-F/A filed by Park Ha Biological Technology Co. Ltd.20-F/A - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- SECSEC Form F-3 filed by Park Ha Biological Technology Co. Ltd.F-3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- INSIDERSEC Form 3 filed by new insider Shan Yanan3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)
- INSIDERSEC Form 3 filed by new insider Li Xinyu3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)
- INSIDERSEC Form 3 filed by new insider Yu Xiaozhong3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)
- INSIDERSEC Form 3 filed by new insider Zhu Xiaoyan3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)
- INSIDERSEC Form 3 filed by new insider Zhang Xiaoqiu3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)
- INSIDERSEC Form 3 filed by new insider Sheng Qixiong3 - Park Ha Biological Technology Co., Ltd. (0001986247) (Issuer)
- SECSEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- SECSEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.6-K - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
- SECSEC Form 20-F filed by Park Ha Biological Technology Co. Ltd.20-F - Park Ha Biological Technology Co., Ltd. (0001986247) (Filer)
BYAH FAQ
5 questionsWhere does BYAH stock trade?
Park Ha Biological Technology Co. Ltd. (BYAH) is listed on NASDAQ.What sector and industry is BYAH in?
Park Ha Biological Technology Co. Ltd. operates in the Consumer Discretionary sector, Package Goods/Cosmetics industry.When did Park Ha Biological Technology Co. Ltd. go public?
Park Ha Biological Technology Co. Ltd. (BYAH) completed its IPO in 2024.What companies are similar to BYAH?
Notable peers in the same industry include PG (Procter & Gamble Company), UL (Unilever PLC), ECL (Ecolab Inc.), CL (Colgate-Palmolive Company), HLN (Haleon plc). Compare BYAH side-by-side with any of them on Quantisnow.How can I track BYAH on Quantisnow?
Quantisnow aggregates Park Ha Biological Technology Co. Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BYAH to receive live email and push alerts on every new disclosure.